Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05215574
Title Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NGM Biopharmaceuticals, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
NGM Clinical Study Site RECRUITING Gilbert Arizona 85234 United States Details
NGM Clinical Study Site RECRUITING Los Angeles California 90025 United States Details
NGM Clinical Study Site RECRUITING Sarasota Florida 34232 United States Details
NGM Clinical Study Site RECRUITING Tampa Florida 33612 United States Details
NGM Clinical Study Site RECRUITING Grand Rapids Michigan 49546 United States Details
NGM Clinical Study Site RECRUITING New York New York 10016 United States Details
NGM Clinical Study Site RECRUITING Oklahoma City Oklahoma 73104 United States Details
NGM Clinical Study Site TERMINATED Austin Texas 78758 United States Details
NGM Clinical Study Site RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field